ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Antonio
Llombart Cussac
Antonio Llombart Cussac-rekin lankidetzan egindako argitalpenak (18)
2019
2018
-
ERþ Breast cancers resistant to prolonged neoadjuvant letrozole exhibit an e2f4 transcriptional program sensitive to cdk4/6 inhibitors
Clinical Cancer Research, Vol. 24, Núm. 11, pp. 2517-2529
2017
-
18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: A window-of-opportunity randomized trial
Clinical Cancer Research, Vol. 23, Núm. 6, pp. 1432-1441
-
Critically short telomeres and toxicity of chemotherapy in early breast cancer
Oncotarget, Vol. 8, Núm. 13, pp. 21472-21482
2012
-
Progress against solid tumors in danger: The metastatic breast cancer example
Journal of Clinical Oncology
2010
-
Current controversies in the management of breast cancer
Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286
-
Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))
Clinical and Translational Oncology
2009
-
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Journal of Clinical Oncology, Vol. 27, Núm. 11, pp. 1753-1760
2008
-
Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007
Clinical and Translational Oncology, Vol. 10, Núm. 9, pp. 552-559
-
Time-to-progression in breast cancer: A stratification model for clinical trials
Breast, Vol. 17, Núm. 3, pp. 239-244
2007
-
Current controversies in the management of early breast cancer
Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 375-384
2006
-
The «El Álamo» project (1990-1997): Two consecutive hospital-based studies of breast cancer outcomes in Spain
Clinical and Translational Oncology, Vol. 8, Núm. 7, pp. 508-518
2005
-
Improvement of breast cancer relapse prediction in high risk intervals using artificial neural networks
Breast Cancer Research and Treatment, Vol. 94, Núm. 3, pp. 265-272
2004
-
Biweekly paclitaxel plus gemcitabine in advanced breast cancer: Phase II trial and predictive value of HER2 extracellular domain
Annals of Oncology, Vol. 15, Núm. 2, pp. 201-206
-
Estudio epidemiológico del grupo GEICAM sobre el cáncer de mama en España (1990-1993): Proyecto «El Álamo»
Medicina Clinica, Vol. 122, Núm. 1, pp. 12-17
-
Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM) [1]
Journal of Clinical Oncology
2003
-
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients
Annals of Oncology, Vol. 14, Núm. 9, pp. 1383-1390
1999
-
Treatment with a nonanthracycline regimen in advanced breast cancer: Vinorelbine, cyclophosphamide, and 5-fluorouracil with folinic acid
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 22, Núm. 2, pp. 196-198